Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database

European Journal of Clinical Pharmacology

Volumn 60, Issue 4, 2004, Pages 279-283

  Clinard, François ^a,b   Sgro, Catherine ^b   Bardou, Marc ^b   Hillon, Patrick ^a   Dumas, Monique ^b   Kreft Jais, Carmen ^c   Escousse, André ^a   Bonithon Kopp, Claire ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Adverse drug reaction; NSAIDs; Pharmacovigilance

Indexed keywords

ACENOCOUMAROL; CLARITHROMYCIN; CLOXACILLIN; ESTRADIOL; GENTAMICIN; GLIBENCLAMIDE; LISINOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN;

ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 3142715305     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0761-0     Document Type: Article

References (17)

1. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888-1899
2. Schoenfeld P, Kimmey MB, Scheiman J, Bjorkman D. Laine L (1999) Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications - guidelines for prevention and treatment. Aliment Pharmacol Ther 13:1273-1285
3. Leddin D (1993) Prophylaxis of NSAID associated gastroduodenal damage: a critical review of risk factors. Can J Gastroenterol 7:440-443
4. National survey of medical prescriptions. Paris: CNAMTS-ENSM-DGASIM; 1996
5. Strom BL (1994) Pharmacoepidemiology, 2nd edn. John Wiley & Sons, Chichester, England
6. Begaud B, Evreux JC, Jouglard J, Lagier G (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40:115-118
7. Desboeuf K, Lapeyre-Mestre M, Montastruc JL (1999) Médicaments inhibiteurs calciques et risque hémorragique gastro-intestinal. Etude pharmaco-épidémiologique cas-non cas. Arch Mal Coeur Vaiss 92:1095-1099
8. Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, et al (1997) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 44:513-518
9. Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937
10. Spigset O, Hedenmalm K (1997) Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions. Pharmacotherapy 17:348-352
11. Stricker BH, Tijssen JG (1992) Serum sickness-like reactions to cefaclor. J Clin Epidemiol 45:1177-1184
12. Stiel D (2000) Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations. Am J Ther 7:91-98
13. Somasundaram S, Hayllar H, Rafi S, Wrigglesworth J, Macpherson A, Bjarnason I (1995) The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 30:289-299
14. Levi S, Shaw-Smith C (1994) Non-steroidal anti-inflammatory drugs: how do they damage the gut ? Br J Rheumatol 33:605-612
15. Ravnskov U (1999) Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol 47:203-210
16. Rabinovitz M, Van Thiel DH (1992) Hepatotoxicity of non-steroidal anti-inflammatory drugs. Am J Gastroenterol 87:1696-1704
17. Bircher AJ (1999) Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 9:657-663